AlloVir (NASDAQ:ALVR – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, March 13th. Analysts expect the company to announce earnings of ($2.76) per share for the quarter.
AlloVir Trading Down 6.8 %
Shares of AlloVir stock opened at $9.20 on Tuesday. The firm has a market capitalization of $46.39 million, a P/E ratio of -0.45 and a beta of 0.63. The business has a fifty day simple moving average of $9.82 and a two-hundred day simple moving average of $13.73. AlloVir has a 12 month low of $7.96 and a 12 month high of $24.15.
AlloVir Company Profile
Featured Stories
- Five stocks we like better than AlloVir
- 3 Ways To Invest In Coffee, Other Than Drinking It
- How to Protect Your Portfolio When Inflation Is Rising
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How Investors Can Find the Best Cheap Dividend Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for AlloVir Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AlloVir and related companies with MarketBeat.com's FREE daily email newsletter.